Pacira BioSciences, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 36.39 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.45B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled dos...